Incyte's Opzelura Wins EU Approval for Atopic Dermatitis

SentiSense · Published · Updated

Incyte's Opzelura has earned European approval for adult patients with moderate atopic dermatitis. This new EU approval may positively impact Incyte's...

Sign in to read the full story. Free accounts include 20 full reads a month.

Sign in or create a free account

Powered by SentiSense - Intelligent Market Analysis